Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer

Among the three primary gynecological malignancies, ovarian cancer has the lowest incidence but the worst prognosis. Because of the poor prognosis of ovarian cancer patients treated with existing treatments, immunotherapy is emerging as a potentially ideal alternative to surgery, chemotherapy, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xukai, Shen, Yini, Huang, Wu, Bao, Yiting, Mo, Jiahang, Yao, Liangqing, Yuan, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
An Inventory of Epithelial Ovarian Cancer Targets: “Evidence-based” Options-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969460/
https://www.ncbi.nlm.nih.gov/pubmed/36826231
http://dx.doi.org/10.1177/10732748231159706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969460/
https://www.ncbi.nlm.nih.gov/pubmed/36826231
http://dx.doi.org/10.1177/10732748231159706

Ejemplares similares